Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Best timing for a midurethral sling during robotic pelvic organ prolapse repair

Official title: Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy

Run by University of Alabama at Birmingham · NCT07008898 · Data updated 2026-11-12

This trial will test whether placing a midurethral sling before or after robotic sacrocolpopexy works better for women with stress urinary incontinence and pelvic organ prolapse.

More Pelvic Organ Prolapse trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment110 (estimated)
SponsorUniversity of Alabama at Birmingham
Academic / other
Locations2 sites (Birmingham, Alabama and 1 other locations)
StatusRecruiting
StartedJuly 8, 2025
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT07008898 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with stage 2–4 pelvic organ prolapse, demonstrable stress urinary incontinence, planning robotic sacrocolpopexy with concomitant retropubic midurethral sling, and able to read English or Spanish.

Probably not a fit

Patients without demonstrable SUI, with prior SUI surgery, bladder capacity <200 mL or PVR >150 mL, current genitourinary fistula or urethral diverticulum, or who cannot read English/Spanish are not eligible and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, noninferiority trial comparing retropubic midurethral sling (RP MUS) placement before versus after robotic-assisted sacrocolpopexy (RSC). Eligible patients are randomized using a variable permuted block scheme via REDCap, with patient blinding to the sequence of sling placement intraoperatively. The trial measures patient symptoms, success rates, and complication rates following the two timing strategies. The goal is to determine whether one sequence yields equal or better continence and safety outcomes.

Why it matters

Potential benefit: If successful, the trial could identify the timing that reduces urine leakage and complications after prolapse repair, improving recovery and outcomes.

How similar studies have gone: Midurethral slings are well established for treating SUI, but randomized data specifically comparing sling placement before versus after robotic sacrocolpopexy are limited, making this sequencing question relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 18 years of age
* Able to speak and read English and Spanish

  * Diagnosis of pelvic organ prolapse stage 2-4
  * Planning to undergo a robotic-assisted sacrocolpopexy
  * Demonstrable SUI (either by CST, with or without prolapse reduction, or UDS) within the year prior to enrollment
  * Planning to undergo concomitant SUI correction with MUS at the time of RSC

Exclusion Criteria:

* Less than 18 years of age
* Unable to speak and read English or Spanish
* No diagnosis of SUI (prophylactic slings)
* History of prior surgery for SUI
* Bladder capacity \<200 mL or post-void residual (PVR) \>150 mL
* Current genitourinary fistula or urethral diverticulum

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • Albany Medical Center
    Albany, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Gabriela E Halder, MD, MPH — University of Alabama at Birmingham
  • Study coordinator: Martha K Coghlan, MD
  • Email: mkcoghlan@uabmc.edu
  • Phone: 6019883613

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.